Pharmacists step in to fight antipsychotic weight gain
NCT ID NCT07446218
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether extra education from a pharmacist can help people aged 18-60 who are starting a new antipsychotic medication for conditions like schizophrenia or bipolar disorder. The goal is to see if this support reduces weight gain and other metabolic side effects. Participants will either receive standard care or additional pharmacist-led counseling sessions over 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Punjab Institute of Mental Health
Lahore, Punjab Province, 54000, Pakistan
-
The University of Lahore
Lahore, Punjab Province, 54000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Seaweed extract may tackle fatty liver Disease—A trial puts it to the test
- Can a structured care pathway ease teen depression?
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Ancient herb huangjing put to the test against hidden belly fat